Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00686998
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Phase IIA Study in Patients With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: AZD2624;   Drug: Olanzapine;   Drug: Placebo

Indicates status has not been verified in more than two years